SHJBF OTC
Shanghai Junshi Biosciences Co., Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +8.8%
1Y: -14.8%
3Y: -40.2%
$3.35
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$12.4B
+14.7% ▲
5Y CAGR: +9.1%
Total Liabilities
$6.2B
+27.0% ▲
5Y CAGR: +23.2%
Shareholders Equity
$6.0B
+2.6% ▲
5Y CAGR: +0.6%
Cash & Investments
$3.2B
+10.3% ▲
5Y CAGR: -1.0%
Total Debt
$4.1B
+41.4% ▲
5Y CAGR: +37.3%
Net Debt
$1.5B
+244.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $3.5B | $6.0B | $3.8B | $2.5B | $2.6B |
| Short-Term Investments | $0 | $1.2B | $0 | $431M | $601M |
| Cash & ST Investments | $3.5B | $6.0B | $3.8B | $2.9B | $3.2B |
| Net Receivables | $1.3B | $233M | $480M | $510M | $522M |
| Inventory | $485M | $599M | $538M | $584M | $573M |
| Other Current Assets | $131M | $123M | $754M | $272M | $3M |
| Total Current Assets | $5.8B | $7.2B | $5.5B | $4.3B | $4.5B |
| Property, Plant & Equip. | $3.4B | $3.0B | $4.3B | $4.6B | $5.0B |
| Goodwill & Intangibles | $52M | $316M | $134M | $121M | $560M |
| Long-Term Investments | $233M | $202M | $1.1B | $796M | $1.9B |
| Other Non-Current Assets | $1.4B | $1.6B | $188M | $892M | $364M |
| Total Non-Current Assets | $5.2B | $5.3B | $5.8B | $6.5B | $7.9B |
| Total Assets | $11.1B | $12.6B | $11.4B | $10.8B | $12.4B |
| — Liabilities — | |||||
| Accounts Payable | $196M | $282M | $247M | $208M | $1.1B |
| Short-Term Debt | $11M | $392M | $539M | $895M | $1.3B |
| Deferred Revenue | $7M | $591K | $0 | $0 | $22M |
| Other Current Liabilities | $433M | $682M | $1.3B | $1.1B | $76M |
| Total Current Liabilities | $2.0B | $1.8B | $2.5B | $2.5B | $2.8B |
| Long-Term Debt | $490M | $840M | $1.2B | $2.0B | $2.8B |
| Other Non-Current Liab. | $134M | $0 | $153M | $158M | $533M |
| Total Non-Current Liabilities | $702M | $1.0B | $1.5B | $2.3B | $3.4B |
| Total Liabilities | $2.7B | $2.8B | $4.0B | $4.8B | $6.2B |
| — Equity — | |||||
| Common Stock | $911M | $983M | $986M | $986M | $1.0B |
| Retained Earnings | -$688M | -$6.8B | -$9.1B | -$10.3B | -$11.2B |
| Accumulated OCI | $1.9B | $2.3B | -$142M | -$160M | -$40M |
| Total Stockholders Equity | $8.0B | $9.5B | $7.2B | $5.9B | $6.0B |
| Total Liabilities & Equity | $11.1B | $12.6B | $11.4B | $10.8B | $12.4B |
| — Key Metrics — | |||||
| Total Debt | $628M | $1.3B | $1.8B | $2.9B | $4.1B |
| Net Debt | -$2.9B | -$4.8B | -$2.0B | $444M | $1.5B |
| Total Investments | $233M | $1.4B | $1.1B | $1.2B | $2.5B |